Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands
Joris van de Haar, Louisa R. Hoes & Emile E. Voest
Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands
Joris van de Haar
Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands
Joris van de Haar, Louisa R. Hoes & Emile E. Voest
Cancer Research UK Cambridge Cancer Center, Cambridge, UK
Charlotte E. Coles, Kenneth Seamon & Carlos Caldas
German Cancer Consortium, Heidelberg, Germany
Stefan Fröhling & Michael Baumann
Division of Translational Medical Oncology, National Center for Tumor Diseases Heidelberg and German Cancer Research Center, Heidelberg, Germany
Stefan Fröhling
Department of Medical Oncology, National Center for Tumor Diseases Heidelberg and Heidelberg University Hospital, Heidelberg, Germany
Dirk Jäger
Università Statale di Milano, Milan, Italy
Franco Valenza & Filippo de Braud
Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy
Franco Valenza, Filippo de Braud & Giovanni Apolone
Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden
Luigi De Petris & Jonas Bergh
Theme Cancer, Karolinska University Hospital, Stockholm, Sweden
Luigi De Petris & Jonas Bergh
Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm, Sweden
Ingemar Ernberg
Gustave Roussy Cancer Campus, Villejuif, France
Benjamin Besse, Fabrice Barlesi & Jean Charles Soria
Aix Marseille University, CNRS, INSERM, CRCM, Marseille, France
Fabrice Barlesi
Department of Medical Oncology, Vall d’Hebron University Hospital, Vall d’Hebron Institute of Oncology, Barcelona, Spain
Elena Garralda, Alejandro Piris-Giménez & Josep Tabernero
German Cancer Research Center, Heidelberg, Germany
Michael Baumann
Department of Oncology and Cancer Research UK Cambridge Institute, Li Ka Shing Center, University of Cambridge, Cambridge, UK
Carlos Caldas